Cohort Company News

Abstract Background and Aims As clinicians prepare to screen and manage the influx of patients with metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic dysfunction–associated... Read More →

Breakthrough Device-Designated Therapy System Takes Important Step Toward Market Authorization PORTLAND, OR, UNITED STATES, March 24, 2026 /EINPresswire.com/ — Madorra Inc., a medical device company... Read More →

Abstract Circulating cell-free nucleic acids (cfDNA and cfRNA) found in blood and other biofluids are promising biomarkers for cancer. However, current methods exploiting tumor-derived cfDNA... Read More →

CNN spoke with the first person in the world to be treated with this futuristic material, called Res-Q-Foam, after he was seriously injured in a... Read More →

CAMBRIDGE, Mass. – March 28, 2026 – Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its... Read More →

SAN DIEGO, March 24, 2026 /PRNewswire/ — Starlight Cardiovascular announced that the first baby in the world was treated with its Lifeline™ Ductus Arteriosus Stent... Read More →

Medical device industry veteran to lead expansion of Saberscope™, the market’s first and only single-use video platform for minimally invasive surgery, laparoscopic procedures, and advanced... Read More →

Matthew Segar, MD, of The Texas Heart Institute, discusses new research evaluating whether AI‑enabled ECG analysis can detect aortic stenosis years before traditional symptom‑driven diagnosis.... Read More →

First clinical cases successfully completed; U.S. launch to be led by Kaneka’s Neurovascular division IRVINE, Calif., March 11, 2026 (GLOBE NEWSWIRE) — Toro Neurovascular today... Read More →

Labcorp Venture Fund, Mayo Clinic, Sutter Health, InterVest, MGFO, PGGM, Puma Venture Capital, and ROM Utrecht invest alongside existing investors Invest-NL, EIC Fund, Fred Moll,... Read More →

New investor Nexpring Health™ joins existing investors, including Sofinnova, Bpifrance, and Trill Impact MENLO PARK, Calif.–(BUSINESS WIRE)–May Health, a medical device company dedicated to helping... Read More →

The landscape of preclinical neuroscience research is shifting. Growing ethical considerations, cost pressures, and translational limitations have accelerated interest in organoid alternatives to animal models... Read More →

In this episode, Armor Medical Co-founder and CEO Kelsey Mayo shares her ultimate entrepreneurial journey. Mayo recognized early on that her career needed to make... Read More →

ABSTRACT Chimeric antigen receptor T (CAR-T) cells have been used to treat patients with glioblastoma (GBM) in clinical trial settings bytargeting GBM-associated antigens. However, the... Read More →

REDWOOD CITY, Calif., Feb. 25, 2026 /PRNewswire/ — Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, announces the closing of $10.7M... Read More →

Liquet Medical Inc., a pioneering medical device company committed to advancing patient care through innovative technologies, today announced it has received a second 510(k) clearance... Read More →

Juan C. Jimenez addresses the heart care crisis in the United States where half of all counties have no specialist to read heart scans. There... Read More →

SALT LAKE CITY, Feb. 24, 2026 /PRNewswire/ — Xenocor, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the new Xenocor... Read More →